Cardiac arrhythmias frequently complicate the clinical management of patients with acute myocardial infarction (AMI). Multiple studies have established a significant association between diverse arrhythmias with a higher morbidity and mortality in …

Acute myocardial infarction is still a leading cause of death worldwide, accounting for roughly three million deaths yearly [ 1 ]. It is estimated that 23.6 million people will die from cardiovascular diseases (CVDs) by 2030 [ 2 ]. Acute coronary …

Acute myocardial infarction (AMI) is a severe type of ischemic heart disease. Globally, approximately 9 and 182 million deaths and disabilities, respectively, were caused by AMI in 2019 [ 1 – 3 ]. Creatine kinase-MB (CK-MB) is a clinically …

Cardiovascular complications are a major cause of morbidity and mortality, particularly in type 2 diabetes mellitus (T2DM) [ 1 ]. Myocardial infarction (MI), results from myocardial ischemia due to a disproportion between myocardial oxygen supply …

Myocardial infarctions (MIs) that are asymptomatic or with minor and atypical symptoms are often diagnosed through routine electrocardiographic (ECG) examination. Silent myocardial infarction (SMI) is characterized by ECG evidence of MI without a …

Coronary heart disease (CHD) is a clinical syndrome associated with the formation of plaques in the arterial intima, leading to the narrowing and eventual occlusion of the vessels. Clinically, CHD primarily manifests as Myocardial Infarction (MI) …

As the most serious ischaemic heart disease, acute myocardial infarction (AMI) is recognized as a leading cause of cardiovascular disease (CVD) morbidity and mortality worldwide [ 1 , 2 ]. AMI causes more than 24 million deaths in the United States …

Cardiac disease is the leading cause of death in both urban and rural residents in China. High long-term mortality is mostly caused by HF and other MACE following AMI [ 1 ]. PCI and guideline-directed medical therapy can reduce the in-hospital …

Ketone bodies including acetoacetate, acetone, and β-hydroxybutyrate (3-βOHB) are synthesized by ketogenesis in the liver and oxidized in various tissues via ketolytic pathways. Under physiological conditions, ketone bodies contribute to 10–20% of …

The occurrence of a post-myocardial infarction ventricular septal perforation (VSP) is an infrequent but often fatal complication, affecting less than 1% of patients who have experienced myocardial infarction (MI) in the modern era of early …

The chronic inflammation in cancer predisposes patients to arterial and venous thromboembolism, including myocardial infarction [ 1 ]. Not only that, but chemotherapy itself is increasingly associated with cardiotoxicity with reported cases of …

Acute myocardial infarction (AMI) is a life-threatening emergency associated with high morbidity and mortality [ 1 , 2 ]. Over the past several decades, advances in evidence-based AMI care, including early diagnosis, rapid reperfusion strategies …

The management of patients with acute myocardial infarction (AMI) and large thrombus burden (LTB) remains challenging. Despite the advent of potent antithrombotic regimens, percutaneous coronary intervention (PCI) in AMI cases with LTB often …